Back to Stakeholders
Clinical Research & Pipeline ProductsConsultancy & Advisory Services

Ketamine Research Institute

United States
16 Trials

The Ketamine Research Institute is a US-based clinical research organization developing precision medicine approaches to ketamine infusion therapy, studying optimized dosing protocols to treat depression and offering clinician training in evidence-based ketamine practice.

Quick Facts

Type
Other
HQ
United States
Website
Visit

Sponsored Trials

2
RecruitingNA

Veterans' Perceptions of Ketamine-Assisted Psychotherapy for Depression and End-of-Life (KAP)

Start Date
CompletedNA

Perceptions of MDMA-Assisted Therapy Among Veterans With PTSD

Start Date

Collaborated Trials

14
CompletedI

PAPR: PAP + MBSR for Front-line Healthcare Provider COVID-19 Related Burnout (PAPR)

Start Date
Compounds
Psilocybin
TerminatedI

Visual Surround Suppression and Perceptual Expectation Under Psilocybin

Start Date
Compounds
Psilocybin, Placebo
RecruitingI

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer’s Disease

Start Date
Compounds
Psilocybin
RecruitingI

Adjunctive Effects of Psilocybin and Buprenorphine

Start Date
Compounds
Psilocybin
CompletedII

Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care

Start Date
Compounds
Psilocybin
CompletedI

Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study

Start Date
Compounds
Psilocybin, Placebo
Active not recruitingI

Psilocybin – Induced Neuroplasticity in the Treatment of Major Depressive Disorder

Start Date
Compounds
Psilocybin, Placebo
CompletedI

Psilocybin for the Treatment of Cluster Headache

Start Date
Compounds
Psilocybin, Placebo
CompletedII

A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence

Start Date
Compounds
Psilocybin, Placebo
CompletedII

Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence

Start Date
Compounds
Psilocybin
CompletedNA

Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study

Start Date
Compounds
Psilocybin, Placebo
CompletedII

Psychopharmacology of Psilocybin in Cancer Patients

Start Date
Compounds
Psilocybin
CompletedI, II

Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety

Start Date
Compounds
Psilocybin, Placebo
CompletedI

Pharmacological Interaction Between Pindolol and MDMA (3,4-Methylenedioxymethamphetamine)

Start Date
Compounds
MDMA